| 1923 |
Privately founded as Mustafa Nevzat Laboratory in Üsküdar/Istanbul, by Prof.
Mustafa Nevzat Pisak who played a great role in establishing contemporary
pharmacy in Turkey.
|
| 1930 |
Registration of Pavotin ampoule produced from opium alkaloids extracted from
poppy seed. |
| 1933 |
Mustafa Nevzat Laboratory, first moved to Divanyolu, then to Nuruosmaniye which
are located in the European part of Istanbul. |
| 1935 |
 Injectable
preparation of powdered insulin was first produced in Turkey by MN
Pharmaceuticals.
|
| 1957 |
Moved to Mecidiyeköy/Istanbul and became a joint stock company. |
| 1961 |
The first enteric-coated tablet was registered in Turkey (Entersal). |
| 1968-1970 |
New Buildings were added to the production and quality control units. |
| 1974 |
Active pharmaceutical ingredients were started to be produced (API). |
| 1977 |
Some galenic forms such as syrups, ointments, creams and dry powder suspensions
were also produced at the temporary building in Yenibosna/Istanbul. |
| 1984 |
Separate production plants was established in Yenibosna to produce finished
dosage forms of penicillin-like beta-lactams (Plant I - Penicillin-like
Beta-lactam Products). |
| 1996 |
Separate production plants at Yenibosna was established to produce finished
dosage forms of cephalosporin-like beta-lactams (Plant II - Cephalosporin-like
Beta-lactam Products). |
| 2003 |
 Yenibosna
Plant III, which is one of the most modern facilities in Turkey, was completed.
This plant is dedicated to non-penicillin and non-cephalosporin finished dosage
forms (Plant III - Other Products).
|
| 2005 |
MN Pharmaceuticals signed strategic partnership agreements with several leading US
generic companies for marketing and sales of its products and has submitted the first
ANDA file to FDA. This is also a “first” for Turkish Pharmaceutical Industry. By
taking the initial step in exporting finished dosage forms to the US, MN Pharmaceuticals has paved
the way for the other Turkish pharmaceutical companies to follow. |
| 2006 |
Our API and finished dosage forms facilities have been inspected by FDA in November 2006.
As a result of FDA inspection, MN Pharmaceuticals is the first Turkish Pharma Company
which has been granted an FDA approval for the API and finished dosage forms. |
| 2007 |
Our finished dosage form facilities have been inspected and approved for the third time
by German Health authorities and EU-GMP Certificate has been granted. (First inspection
was performed in July, 2004.) |
